Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
about
Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.Are we ready to use aliskiren in children?Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
P2860
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
@en
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
@nl
type
label
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
@en
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
@nl
prefLabel
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
@en
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
@nl
P2860
P1433
P1476
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.
@en
P2093
Rakesh Bhattacharjee
P2860
P2888
P304
P356
10.1007/S00467-002-0829-Y
P50
P577
2002-04-01T00:00:00Z
P6179
1043337128